Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the closing […]
4D Biomaterials Completes £1.6m ($2.2m) Seed Round
4D Biomaterials has just completed a £1.6m ($2.2m) seed investment round led by DSW Ventures […]
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 Million Doses of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today […]
OPEN Health Acquires Medical Communications Agency Spirit
OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit. […]
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology Across Vaccines and Therapeutics Development
As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop […]
Wellbeing Platform 87% Raises £1.6million in Funding in Just Two Weeks
Leading workplace wellbeing platform 87% has raised £1.6 million in seed funding to accelerate its […]
SynOx Therapeutics Further Strengthens Team with Appointments of Chief Medical Officer and Chief Technology Officer
SynOx Therapeutics Limited (“SynOx” or the “Company”), the late-stage clinical biopharmaceutical company developing emactuzumab for […]
SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer
CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance […]
Healthera Announces Partnership with Alliance Healthcare to Drive Forward the Digital Agenda Within Community Pharmacies
Today, Healthera is pleased to announce a partnership with Alliance Healthcare. Alliance Healthcare is the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more